glp 1 microdose for menopause How microdosing GLP-1 drugs became a wellness 'craze' How microdosing GLP-1 drugs became
Description
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021
With GLP-1 weight loss comes muscle loss
Results Mean weight dropped from 133 to 87 kg by year 2, with %EWL peaking at 68% and declining to 63% by year 5
THIRD-PARTY TESTED, AND DOCTOR RECOMMENDED: Manufactured in the USA in FDA-reviewed, NSF and GMP certified facilities to ensure the highest standards of safety and effectiveness
